300+ investors in your industry, stage, and region Get
Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Artificial Intelligence
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Payments
Email
Photography
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Crowdfunding
Theatre
Recruiting
Web3
Venture Capital
Medical
LGBT
Cannabis
Fashion
Climate
Celebrity
Beauty
Mobile Apps
Wine and Spirits
Social
Infrastructure
Music
Sporting Goods
Real Estate
Art
Food and Beverage
Publishing
Digital Media
FinTech
Life Science
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Manufacturing
Internet
Android
Finance
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Gibraltar
Burkina Faso
Africa
Brazil
Singapore
Oceania
Egypt
LATAM
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Liberia
Malawi
Mexico
Nigeria
Tajikistan
Tunisia
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Madagascar
Pakistan
Romania
Oman
Poland
Puerto Rico
Andorra
Guernsey
Cameroon
Sudan
Colombia
Armenia
China
Costa Rica
Czech Republic
Kuwait
Kenya
Marshall Islands
Luxembourg
Malta
Mauritius
Namibia
Mozambique
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Jamaica
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Canada
South Africa
France
Georgia
Denmark
Ghana
Ireland
Iraq
Latvia
Malaysia
Philippines
Portugal
Mali
Rwanda
Sierra Leone
Senegal
Tanzania
India
Germany
United States
Indonesia
El Salvador
Middle East
Bermuda
Dominican Republic
Asia
Albania
Qatar
Argentina
Spain
Bangladesh
Barbados
Belgium
Angola
Europe
Austria
Ethiopia
Cyprus
Jordan
Azerbaijan
Bulgaria
Ecuador
Bolivia
Estonia
Faroe Islands
Jersey
Belize
Bahrain
Bahamas
Algeria
Italy
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Belarus
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Kutxa Fundazioa, VC Fund

Kutxa Fundazioa

VC Fund

Donostia-san Sebastián, Spain

Kutxa Fundazioa is a VC fund in Donostia-san Sebastián focused on Biotechnology and Software. Kutxa Fundazioa contributes to strengthening a sustainable, competitive, and innovative business network in Gipuzkoa.

Total investments:
3
Last investment:
Lead investor:
0%

Last updated:

Industries Kutxa Fundazioa invests in

BiotechnologySoftwareBiopharmaHealth CareMachine Learning

Stages Kutxa Fundazioa invests in

Venture - Series UnknownSeries C

Countries Kutxa Fundazioa invests in

Spain

Investment Focus

Industry

  • Biotechnology 2 (67%)
  • Software 1 (33%)
  • Biopharma 1 (33%)
  • Health Care 1 (33%)
  • Machine Learning 1 (33%)
See all 7 industries →

Stage

  • Venture - Series Unknown 2 (67%)
  • Series C 1 (33%)

Investments

CompanyDescriptionRoundLinks
Multiverse Computing Multiverse Computing
Multiverse Computing creates quantum computing software that uses probabilistic or nondeterministic technology to solve complicated real-world challenges. The company provides software tailored to the needs of portfolio optimization challenges, risk analysis, and market simulation, giving companies in a variety of industries, including banking,energy, manufacturing, and logistics, the opportunity to benefit from the second quantum revolution. $569.6M / Series C / Jul 27, 2026
Oncomatryx Oncomatryx
Oncomatryx is a biopharmaceutical company focused on the tumor microenvironment.Oncomatryx has developed precision drugs and diagnostic devices that target the tumor stroma.Oncomatryx Antibody-Drug Conjugates (ADCs) and human-derived proteins target peritumoral fibroblasts, endothelial cells and extracellular matrix that promote tumorinvasiveness, drug resistance and immunosuppression.Oncomatryx ADCs bear novel proprietary payloads and linker derivatives that render an optimal therapeutic index against pancreatic cancer in vivo. Oncomatryx OMTX705, an ADC which targets cancer-associated fibroblasts (CAFs), inhibits pancreatic tumor growth in patient-derived xenograft mice, both as single agent and in combination with chemotherapy. $67.3M / Venture - Series Unknown / Mar 23, 2026
Polimerbio Polimerbio
A new generation of materials for biomedical devices that improve the quality of life and an efficient medicine. $528.4K / Venture - Series Unknown / Dec 17, 2025

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Artificial Intelligence
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Payments
Email
Photography
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Crowdfunding
Theatre
Recruiting
Web3
Venture Capital
Medical
LGBT
Cannabis
Fashion
Climate
Celebrity
Beauty
Mobile Apps
Wine and Spirits
Social
Infrastructure
Music
Sporting Goods
Real Estate
Art
Food and Beverage
Publishing
Digital Media
FinTech
Life Science
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Manufacturing
Internet
Android
Finance
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Gibraltar
Burkina Faso
Africa
Brazil
Singapore
Oceania
Egypt
LATAM
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Liberia
Malawi
Mexico
Nigeria
Tajikistan
Tunisia
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Madagascar
Pakistan
Romania
Oman
Poland
Puerto Rico
Andorra
Guernsey
Cameroon
Sudan
Colombia
Armenia
China
Costa Rica
Czech Republic
Kuwait
Kenya
Marshall Islands
Luxembourg
Malta
Mauritius
Namibia
Mozambique
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Jamaica
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Canada
South Africa
France
Georgia
Denmark
Ghana
Ireland
Iraq
Latvia
Malaysia
Philippines
Portugal
Mali
Rwanda
Sierra Leone
Senegal
Tanzania
India
Germany
United States
Indonesia
El Salvador
Middle East
Bermuda
Dominican Republic
Asia
Albania
Qatar
Argentina
Spain
Bangladesh
Barbados
Belgium
Angola
Europe
Austria
Ethiopia
Cyprus
Jordan
Azerbaijan
Bulgaria
Ecuador
Bolivia
Estonia
Faroe Islands
Jersey
Belize
Bahrain
Bahamas
Algeria
Italy
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Belarus
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Kutxa Fundazioa invest in?

Kutxa Fundazioa invests primarily in Biotechnology, Software and Biopharma startups, most often at Venture - Series Unknown and Series C stage. Most of the 3 investments tracked by Shizune back companies in Spain. The Investment Focus section breaks down every industry, stage and country in the portfolio.

When did Kutxa Fundazioa last invest?

The most recent investment recorded for Kutxa Fundazioa closed in Jul 2026. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Kutxa Fundazioa Kutxa Fundazioa Find emails